Zacks Investment Research on MSN2d
Pharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline UpdateNovo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...
Sun Pharmaceutical Industries announces acquisition of US-based Checkpoint Therapeutics for up to USD 355 million. The Indian ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback